The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Fedin A.I.

Kafedra nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Solov'eva É.Iu.

Kafedra nevrologii FUV GOU VPO RGMU, Moskva

Topiramate in clinical practice

Authors:

Fedin A.I., Solov'eva É.Iu.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(11‑2): 4‑9

Read: 5029 times

Download PDF (RU)
Contact the author
Table of contents

TOPIRAMATE IN CLINICAL PRACTICE
TOPIRAMATE IN CLINICAL PRACTICE

To cite this article:

Fedin AI, Solov'eva ÉIu. Topiramate in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(11‑2):4‑9. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Clinical and epidemiological indi­cators of stroke during the COVID-19 pandemic and in the post-COVID period in the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):5-11
Brain microstructural abno­rmalities asse­ssed by diffusion kurtosis MRI in patients with focal temporal lobe epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):171-177
Comparative analysis of the resu­lts of treatment of gastric polyps by methods of loop electroexcision, laser and endo­scopic poly­pectomy with aspi­ration capture. Endo­scopic Surgery. 2024;(6):24-30
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712
Ototoxicity caused by anti-epileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):14-19
Abse­nce status epilepticus in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):47-56
Como­rbid anxiety diso­rders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment stra­tegy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):126-136
Resu­lts of the All-Russian consensus conference on complications in bariatric surgery. Endo­scopic Surgery. 2025;(1):15-24
Auto­nomic cardiovascular diso­rders in patients with epileptic and psychogenic non-epileptic seizures: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):13-20
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77
Abstract:

Keywords:

topiramate
treatment
epilepsy

Authors:

Fedin A.I.

Kafedra nevrologii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta

Solov'eva É.Iu.

Kafedra nevrologii FUV GOU VPO RGMU, Moskva

Close metadata

References:

  1. Algoritmy vybora preparatov v lechenii fokal'noi epilepsii. RMZh 2004;12:5:270-275.
  2. Strategiya i taktika terapii epilepsii segodnya. Zhurn nevrol psikhiatr 2004;104:8 28-34.
  3. Topiramat v lechenii epilepsii u vzroslykh. Vestn epileptol 2006;1:3-5.
  4. Kriterii otsenki kachestva lecheniya simptomaticheskoi epilepsii preparatami keppra i topamaks. Zhurn nevrol psikhiatr 2007;107:7:15-19.
  5. and the topiramate YOL study group. Topiramat in the long-term management of refractory epilepsy. Epilepsia 2000;41:Suppl 1:72-76.
  6. American College of Endocrinology Pre-Diabetes Consensus Conference: Part Two. Diabet Care 2008;31:2222-2229.
  7. Neuropsych Dis Treatment 2006;2:3:261-267.
  8. Rational combination therapy in epilepsy. II. Clinical and pharmacological aspects. Rev Neurol 2007;45:163-173.
  9. Preliminary results in primary generalized seizures. Topiramate: Closing the therapeutic gap in epilepsy (3 September 1996). Abstracts of symposium in conjunction with the second. Eur Congress Epileptol 1996;7.
  10. Clinical efficacy of topiramate as addon therapy in refractory partial epilepsy: the European experience. Epilepsia 1997;38:Suppl 1:28-30.
  11. Preliminary openlabel experience with topiramate in primery generflized seizures. Epilepsia 1997;38:Suppl 1:42-44.
  12. Obshcheevropeiskie standarty pomoshchi pri epilepsii. Soobshchenie komissii Mezhdunarodnoi ligi bor'by s epilepsiei (ILAE).
  13. Topiramat monotherapy and evaluation of plasma levels poster abstract. Neuroscience in action: from clinical dilemma to the therapeutic breakthrough. Conference. Hamburg (Germany) 2002;188.
  14. Topiramate, carbamazepine and valproate monotherapy in children with newly diagnosed epilepsy. Epilepsia 2001;42:2:87.
  15. Plasma pharmacokinetics of topiramate, a new anticonvulsant in humans. Epilepsia 1988;29:662.
  16. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience . Epilepsia 1997;38:Suppl 1:24-27.
  17. Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: experience in the United Staits with tree novel drugs. Epilepsia 1996;37:Suppl 2:23-26.
  18. The steadystate (SS) pharmacokinetics of phenitoin (dilantin) and of topiramate (topamax) in epileptic patients on monotherapy and during combination therapy. Epilepsia 1994;35:Suppl 8:54.
  19. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999;40:985-991.
  20. Expert Opion Pharmacother 2006;7:6:811-823.
  21. Advances in disease modification: protecting the immature brain from neuronal insults (abstract). Neuroscience in Action: from Clinical Dilemma to Therapeutic Breakthrough (Conference 22-23 March 2002, Hamburg, Germany). Hamburg 2002;50.
  22. JAMA 2004;291:5:615-620.
  23. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy. Min Rev Med Chem 2008;8:10-23.
  24. Tolerability of newer and older antiepileptic drugs: a comparative review. CNS Drugs 1996;6:148-166.
  25. Efficacy of topiramate in adult patients with symptomatic epilepsy: an open-label, long-term, retrospective observation. CNS Drugs 2009;23:4:351-359.
  26. Clinical trials versus clinical experience: defining best dosages of antiepileptic drugs (Abstract). Neuroscience in action: from clinical dilemma to therapeutic breakthrough. (Conference, Hamburg, Germany, march 2002). Hamburg 2002;46.
  27. Topiramate: a review of its use in the treatment of epilepsy. Drugs 2007;67:2231-2256.
  28. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Ass 2007;11:1-134.
  29. Topiramate in patients with epilepsy and intellectual disability. Epilepsy Behav 2009;14:3:496-502.
  30. Topiramate. Drugs Future 1989;14:324.
  31. Nonfocal generalized tonicclonic seizures: response during longterm topiramate treatment. Epilepsia 2000;41:Suppl 1:77-81.
  32. Estimation of the absolute bioavailability of topiramate in humans without intravenous date. J Clin Pharmacol 1994;34:1029.
  33. NICE. Technology appraisal 79: newer drugs for epilepsy in adults. London: National Institute of Clinical Ecellence 2004.
  34. Topiramate placebocontrolled dose ranging trial in refractory partial epilepsy using 600, 800, and 1000mg daily dosages. Neurology 1996;46:178:1683.
  35. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003;107:3:165-175.
  36. et. al. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures:retrospective survey of open-label treatment. Epilepsia 1997;38:Suppl 1:34-36.
  37. The pilot study of topiromate for alcohol withdrawal syndrome. Alcohol Alcoholism 2003;38:5:508-509.
  38. Steadystate pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia 1996;37:774-780.
  39. Topiramate monotherapy for partial onset seizures. Epilepsia 1997;38:3:294-300.
  40. Topiramate: clinical profile in epilepsy. Clin Pharmacokinet 1998;34:335-346.
  41. Openlabel study with topiramate monotherapy of newly diagnosed epilepsy in adults (poster abstract). Neuroscience in action: from clinical dilemma to the therapeutic breakthrough (Conference Hamburg, Germany, March 2002). Hamburg 2002;220.
  42. Practical aspects of the use of topiramate in patients with epilepsy. Epilepsia 1997;38:Suppl 1:56-58.
  43. Topiramate in the treatment of substance -related disorders: a critical review of the literature. J Clin Psychiatry 2010;71:5:634-648.
  44. Overview of the Safety of newer antiepileptic drugs. Epilepsia 1997;38:Suppl 1:45-51.
  45. Topiramat add-on: clinical experience in 746 patients with epilepcy. Epilepsia 2002;43:Suppl 8:149.
  46. for the MIGR-001 Study Group. Topiramat v profilaktike migreni: rezul'taty krupnogo kontroliruemogo issledovaniya (referat). Kardiologiya 2004;14:91.
  47. Discovery of antiepileptic drugs. Neurotherapeutics 2007;4:12-17.
  48. Novel anticonvulsant drugs. Pharmacol Ther 2007;113:165-183.
  49. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-768.
  50. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Ass 2005;9:15:1-157.
  51. Evaluation of the absorption, excretion pharmacokinetics and metabolism of the anticonvulsant topiramate in healthy men (Abstract). Pharmacol Res 1994;11:Suppl:336.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.